University of Iowa thinkers, explorers, mentors, creators and inventors were celebrated for their work during the Office of Research and Economic Development’s annual Discovery & Innovation Awards Ceremony Tuesday.
Titled “Celebrating Excellence,” the 2018 event at Hancher brought together faculty, staff and students involved in research and scholarship as well as its translation into medical devices, startup companies and other commercial ventures.
John Keller, interim Vice President for Research and Economic Development and dean of the Graduate College, said that because of the work being done by the people being recognized Tuesday night, “lives are being saved, prolonged, and improved, and our ideas about the vast universe we inhabit, and the innermost workings of the human body, are growing by leaps and bounds.”
Keller, who presented the awards along with interim Provost Sue Curry, said that the attendees’ work is being done during challenging times for research, scholarship and for higher education.
“I want to be the first tonight to thank you for the great energy, dedication, and focus you bring to campus each day,” Keller said. “And to encourage you to keep fighting the good fight. The university, and quite literally the world, depend upon it.”
Following is a list of the award winners. Images of the event are available on Flickr.
Scholar of the Year Award: Nick Bowman, Professor in the College of Education’s Department of Educational Policy and Leadership Studies. The award celebrates nationally recognized achievement in outstanding research, scholarly and/or creative activities by tenure- and/or research-clinical-track faculty members within the previous 24-month period.
Early Career Scholar of the Year Award: Inara Verzemnieks, Assistant Professor in the Department of English in the College of Liberal Arts and Sciences. The award honors assistant professors who are in tenure-track, research-track, or clinical-track positions, have no more than four years of Postdoctoral and/or Fellowship experience, are involved in research, scholarship and/or creative activity, and who show promise of making a significant contribution to their field.
Leadership in Research Award: Robert Wallace, Professor in the Department of Epidemiology in the College of Public Health. This is a lifetime achievement award to honor tenure- , research- or clinical-track faculty for distinguished leadership in research and scholarship accomplishments over a career.
Distinguished Achievement in Publicly Engaged Research Award: Douglas Baynton, Professor in the Department of History, College of Liberal Arts and Sciences, with a joint appointment in the American Sign Language program. The award recognizes a faculty member who has put addressing public needs and direct public engagement in the service of improving quality of life through research at the forefront of his or her academic activities.
Distinguished Achievement in Arts and Humanities Award: John D'Agata, the M.F. Carpenter Professor of English in the Department of English within the College of Liberal Arts and Sciences. The award recognizes a distinguished achievement in humanities scholarship and work in the creative, visual and performing arts.
Communicating Ideas Award: Deborah Reed, Associate Professor in the College of Education’s Department of Teaching and Learning and Director of the Iowa Reading Research Center. The award recognizes excellence in communication about research and scholarship in the sciences and humanities and the study of creative, visual and performing arts to a general audience directly or via print and electronic media.
Distinguished Research Administrator Award: Dixie Ecklund, Director of Operations in the College of Public Health’s Clinical Trials Statistical and Data Management Center. The award recognizes staff members at the University of Iowa who are exceptional research administrators and/or performed exceptional service in support of research. The award is co-sponsored by the Senior Vice President for Finance and Operations and the Vice President for Research & Economic Development.
Distinguished Research Professional Award: Lori Dolan, Associate Research Scientist in the Carver College of Medicine’s Department of Orthopaedics and Rehabilitation. The award recognizes staff members at the University of Iowa who are exceptional research administrators and/or performed exceptional service in support of research. The award is co-sponsored by the Senior Vice President for Finance and Operations and the Vice President for Research & Economic Development.
Graduate Student Research Excellence Awards, which honor graduate students in terminal degree programs conducting research and scholarly activity that is recognized as highly original work. This year’s five recipients are:
- Graduate Student Research Excellence Award in Biology, Life, Mathematical and Physical Sciences.
- Kareem Ebeid, a Ph.D. candidate in the College of Pharmacy’s Department of Pharmaceutical Sciences and Experimental Therapeutics.
- Angela Toepp, a Ph.D. candidate in the College of Public Health’s Department of Epidemiology.
- Graduate Student Research Excellence Awards in Arts and Humanities.
- Kelsey Kramer McGinnis, a Ph.D. candidate in the College of Liberal Arts and Sciences’ School of Music.
- Stefan Schoeberlein, a Ph.D. candidate in the College of Liberal Arts and Sciences’ Department of English.
- Graduate Student Research Excellence Award in Social Sciences.
- Zhenyu Yuan, a Ph.D. student in the Tippie College of Business’s Department of Management & Organizations.
Student Innovator Award, which honors undergraduate and/or graduate students conducting research/scholarly innovation or new technology development that is recognized as highly original work and has led to intellectual property.
- Gurjap Singh, a Ph.D. candidate in the College of Engineering’s Department of Mechanical Engineering.
Excellence in Undergraduate Research Award
- Jesse Cochran
- Evan Lamb
- Mikaela Mallin
- Ojas Pradhan
Distinguished Mentor Award
- Antentor O. Hinton Jr., a Postdoctoral Research Fellow in the Carver College of Medicine’s Francis M. Abboud Cardiovascular Research Center.
- Joyce Tsai, Clinical Associate Professor in the College of Education.
Student Startup of the Year Award
- ABAL Therapeutics
- Premiere Dance Project
Faculty/Staff Startup of the Year: iotaMotion, founded by Christopher Kaufmann, an Otolaryngology Resident in the Carver College of Medicine, and Marlan Hansen, Faculty, department of Otolaryngology and Senior Associate Director of the Institute for Clinical and Translational Science.
Faculty/Staff Startups Launched
- ReadyFor.Surgery, founded by Jacob Thomas, Clinical Assistant Professor of Anesthesia in General and Vascular Anesthesia, in the Carver College of Medicine. .
- Theion Agriculture, LLC, founded by Ned Bowden, Professor in the College of Liberal Arts and Sciences’ Department of Chemistry, and cofounded by Justin Carter, a Ph.D. candidate and Graduate Teaching Assistant in the Department of Chemistry.
- Prova Therapeutics, founded by Alexander Bassuk, Professor in the Carver College of Medicine’s Departments of Neurology and Pediatric Neurology, and Vinit Mahajan, Clinical Assistant Professor of Ophthalmology and Visual Sciences in the Carver College of Medicine.
- Research X, founded by Jun Wang, Professor in the College of Engineering’s Department of Chemical and Biochemical Engineering, and Jing Zeng, a Lecturer in Chemical and Biochemical Engineering
- Brain Wave Solutions , founded by Adam Schwalje, in the Carver College of Medicine’s Department of Otolaryngology and the College of Liberal Arts and Sciences’ Department of Communication Sciences & Disorders.
- Cardio Diagnostics, LLC, founded by Robert Philibert, Professor in the Carver College of Medicine’s Department of Psychiatry.
- Zwicoat Materials Innovations, LLC, founded by Marlan Hansen, Professor, departments of Otolaryngology and Neurology in the Carver College of Medicine, and Allan Guymon, Professor in the College of Engineering’s Department of Chemical and Biochemical Engineering.
Patents
Between January 1 and December 31, 2017, the University of Iowa Research Foundation (UIRF) awarded a total of 27 U.S.-issued patents and 42 foreign-issued patents (and two copyrights). This was a result of 36 invention disclosure submitted by 47 inventors who are still with the UI today. Following is a list of those patent recipients:
|
Inventor |
Patent Title |
Filing Country |
|
Michael D. Abramoff, M.D., Ph.D. |
Automated Assessment of Glaucoma Loss from Optical Coherence Tomography |
United States |
|
Christopher M. Adams, M.D., Ph.D. |
Methods for Inhibiting Muscle Atrophy |
Australia |
|
Christopher M. Adams, M.D., Ph.D. |
Compositions Comprising Ursolic Acid and Derivatives Thereof and Uses Thereof |
Israel |
|
Christopher M. Adams, M.D., Ph.D. |
Methods for Inhibiting Muscle Atrophy |
Israel |
|
Christopher M. Adams, M.D., Ph.D. |
Methods for Inhibiting Muscle Atrophy |
Japan |
|
Christopher M. Adams, M.D., Ph.D. |
Methods for Inhibiting Muscle Atrophy |
Japan |
|
Thomas Edward Baer |
Positioning Device for Ankle Joint Replacement Surgery |
United States |
|
Gail A. Bishop, Ph.D. |
Methods of Improving Vaccine Immunogenicity |
Australia |
|
Ryan L. Boudreau, Ph.D. |
Reduction of Off-Target RNA Interference Toxicity |
Europe |
|
Ryan L. Boudreau, Ph.D. |
Modified Adeno-Associate Virus Vector Compositions |
United States |
|
Ryan L. Boudreau, Ph.D. |
Reduction of Off-Target RNA Interference Toxicity |
United States |
|
David E. Elliott, M.D., Ph.D. |
Parasitic Biological Agents for Treatment and Prevention of Graft Versus Host Disease |
United States |
|
John F. Engelhardt, Ph.D. |
Chimeric Adeno-Associated Virus/Bocavirus Parvovirus Vector |
United States |
|
Michael E. Flatte, Ph.D. |
Voltage-Controlled Magentic-based Devices Having Topological Insulator/Magnetic Insulator Heterostructure |
United States |
|
Ryan Thomas Flynn, Ph.D. |
Method and System for Dynamically-trimmed Spot Scanning for Ion Therapy |
United States |
|
Sean M. Geary, Ph.D. |
Biodegradable Particulate Formulations |
United States |
|
Paloma H. Giangrande, Ph.D. |
Nucleic Acid Aptamers |
United States |
|
Kristina K. Greiner |
MRI/Ultrasound Fusion for Targeted Prostate Biopsy |
United States |
|
Eric A. Hoffman, Ph.D. |
Methods and Devices for Labeling and/or Matching |
United States |
|
Matthew A. Howard, III, M.D. |
Managing Back Pain by Applying a High Frequency Electrical Stimulus Directly to the Spinal Cord |
China |
|
Matthew A. Howard, III, M.D. |
Managing Back Pain by Applying a High Frequency Electrical Stimulus Directly to the Spinal Cord |
Europe |
|
Matthew A. Howard, III, M.D. |
Managing Back Pain by Applying a High Frequency Electrical Stimulus Directly to the Spinal Cord |
Japan |
|
Matthew A. Howard, III, M.D. |
System that Secures an Electrode Array to the Spinal Cord for Treating Back Pain |
United States |
|
Richard R. Hurtig, Ph.D. |
Methods and Systems for Augmentative and Alternative Communications |
United States |
|
Daniel E. Hyer, Ph.D. |
Method and System for Dynamically-trimmed Spot Scanning for Ion Therapy |
United States |
|
Mirac Nedim Ince, M.D. |
Parasitic Biological Agents for Treatment and Prevention of Graft Versus Host Disease |
United States |
|
Adisa Kuburas |
Use of ANti-CGRP of Anti-CGRP_R Antibodies or Antibody Fragments to Treat or Prevent Chronic and Acute Forms of Diarrhea |
Australia |
|
Adisa Kuburas |
Use of ANti-CGRP of Anti-CGRP_R Antibodies or Antibody Fragments to Treat or Prevent Chronic and Acute Forms of Diarrhea |
Japan |
|
Adisa Kuburas |
Use of Anti-CGRP Antibodies and Antibody Fragments to Prevent or Inhibit Photophobia or Light Aversion in Subjects in Need Thereof, Especially Migraine Sufferers |
United States |
|
Leonard R. MacGillivray, Ph.D. |
Co-Crystals and Salts of Contrast Agents and Imaging |
United States |
|
James H. McLinden, Ph.D. |
GB Virus C (Hepatitis G Virus) E2 Glycoprotein as an Immunomodulatory Agent |
United States |
|
James O. McNamara, Ph.D. |
Oligonucleotide-Based Probes for Detection of Bacterial Nucleases |
United States |
|
Steven Richard Mickelsen, M.D. |
Catheters, Catheter Systems, and Methods for Puncturing Through a Tissue Structure and Ablating a Tissue Region |
United States |
|
Jonathon T. Olesberg, Ph.D. |
AugerRate |
United States |
|
Hiroyuki Oya, M.D., Ph.D. |
System that Secures an Electrode Array to the Spinal Cord for Treating Back Pain |
United States |
|
Andrew A. Pieper, M.D., Ph.D. |
Neuroprotective Chemicals and Methods for Identifying and Using Same |
United States |
|
Joseph M. Reinhardt, Ph.D. |
Methods and Devices for Labeling and/or Matching |
United States |
|
Andrew F. Russo, Ph.D. |
Use of ANti-CGRP of Anti-CGRP_R Antibodies or Antibody Fragments to Treat or Prevent Chronic and Acute Forms of Diarrhea |
Australia |
|
Andrew F. Russo, Ph.D. |
Use of ANti-CGRP of Anti-CGRP_R Antibodies or Antibody Fragments to Treat or Prevent Chronic and Acute Forms of Diarrhea |
Japan |
|
Andrew F. Russo, Ph.D. |
Use of Anti-CGRP Antibodies and Antibody Fragments to Prevent or Inhibit Photophobia or Light Aversion in Subjects in Need Thereof, Especially Migraine Sufferers |
United States |
|
Aliasger K. Salem, Ph.D. |
Biodegradable Particulate Formulations |
United States |
|
Michael K. Schultz, Ph.D. |
Compositions and Methods of Treating Cancer |
United States |
|
Seiji Shibata, M.D., Ph.D. |
Methods to Prevent and Treat Autosomal Dominant Non-Syndromic Hearing Loss |
United States |
|
Richard J.H. Smith, M.D. |
Use of Soluble CR1 to Treat DDD/aHUS/GN-C3 |
Japan |
|
Richard J.H. Smith, M.D. |
Treatment of Chronic Nephropathies Using Soluble Complement Receptor Type I (sCR1) |
United States |
|
Richard J.H. Smith, M.D. |
Methods to Prevent and Treat Autosomal Dominant Non-Syndromic Hearing Loss |
United States |
|
Milan Sonka, Ph.D. |
Automated Assessment of Glaucoma Loss from Optical Coherence Tomography |
United States |
|
Milan Sonka, Ph.D. |
Methods and Devices for Labeling and/or Matching |
United States |
|
Douglas R. Spitz, Ph.D. |
Compositions and Methods of Treating Cancer |
United States |
|
Jack T. Stapleton, M.D. |
GB Virus C (Hepatitis G Virus) E2 Glycoprotein as an Immunomodulatory Agent |
United States |
|
David A. Stoltz, M.D., Ph.D. |
Transgenic Pig Models of Cystic Fibrosis |
United States |
|
Manish Suneja, M.D. |
Compositions Comprising Ursolic Acid and Derivatives Thereof and Uses Thereof |
Israel |
|
Manish Suneja, M.D. |
Methods for Inhibiting Muscle Atrophy |
Japan |
|
William H. Thiel, Ph.D. |
Nucleic Acid Aptamers |
United States |
|
Chad R. Tracy, M.D. |
MRI/Ultrasound Fusion for Targeted Prostate Biopsy |
United States |
|
Tony J Vanden Bush, Ph.D. |
Methods of Improving Vaccine Immunogenicity |
Australia |
|
Dongxu Wang, Ph.D. |
Method and System for Dynamically-trimmed Spot Scanning for Ion Therapy |
United States |
|
George J. Weiner, M.D. |
Immunostimulatory Nucleic Acid Molecules |
Europe |
|
George J. Weiner, M.D. |
Biodegradable Particulate Formulations |
United States |
|
George J. Weiner, M.D. |
Parasitic Biological Agents for Treatment and Prevention of Graft Versus Host Disease |
United States |
|
Michael J. Welsh, M.D. |
Methods for Inhibiting Muscle Atrophy |
Australia |
|
Michael J. Welsh, M.D. |
Compositions Comprising Ursolic Acid and Derivatives Thereof and Uses Thereof |
Israel |
|
Michael J. Welsh, M.D. |
Methods for Inhibiting Muscle Atrophy |
Israel |
|
Michael J. Welsh, M.D. |
Methods for Inhibiting Muscle Atrophy |
Japan |
|
Michael J. Welsh, M.D. |
Methods for Inhibiting Muscle Atrophy |
Japan |
|
Michael J. Welsh, M.D. |
Transgenic Pig Models of Cystic Fibrosis |
United States |
|
David F. Wiemer, Ph.D. |
Schweinfurthin Analogues |
Australia |
|
David F. Wiemer, Ph.D. |
Therapeutic Bisphosphonates |
Australia |
|
David F. Wiemer, Ph.D. |
Schweinfurthin Analogues |
China |
|
David F. Wiemer, Ph.D. |
Schweinfurthin Analogues |
Europe |
|
David F. Wiemer, Ph.D. |
Therapeutic Bisphosphonates |
Japan |
|
David F. Wiemer, Ph.D. |
Therapeutic Bisphosphonates |
United States |
|
Jinhua Xiang, M.D. |
GB Virus C (Hepatitis G Virus) E2 Glycoprotein as an Immunomodulatory Agent |
United States |
|
Ziying Yan, Ph.D. |
Chimeric Adeno-Associated Virus/Bocavirus Parvovirus Vector |
United States |
|
Yuzhou Zhang, Ph.D. |
Use of Soluble CR1 to Treat DDD/aHUS/GN-C3 |
Japan |
|
Yuzhou Zhang, Ph.D. |
Treatment of Chronic Nephropathies Using Soluble Complement Receptor Type I (sCR1) |
United States |
Licenses and Options
Between January 1 and December 31, 2017, the University of Iowa Research Foundation (UIRF) executed a total of 54 license and/or option agreements. The exact breakdown for 2017 is as follows: 39 license agreements and 15 option agreements. This was a result of 68 invention disclosures submitted by 65 inventors who are still with the UI today. Following is a list of those license and option recipients:
|
Company |
Inventor |
Case Title |
|
Amgen Inc |
Andrew F. Russo, Ph.D. |
RAMP1 Transgenic Mouse |
|
Applied Biological Materials Inc. |
Aloysius J. Klingelhutz, Ph.D. |
Human Epithelial Cells Immortalized by HPV E6/E7 |
|
BASF Corporation |
James Gloer, Ph.D. |
Penifulvin A: A Sesqquiterpenoid-Derived Metabolite Containing a Novel Dioxa[5,5,5,6]fenestrane Ring System from a Fungicolous Isolate of Penicillium griseofulvum |
|
Cardio Diagnostics, LLC |
Meeshanthini Dogan, M.S. |
Methylation and GxMethylation Effects in Predicting Cardiovascular Disease |
|
Cardio Diagnostics, LLC |
Meeshanthini Dogan, M.S. |
Methylation and GxMethylation Effects in Predicting Stroke, Congestive Heart Failure and Diabetes |
|
Cardio Diagnostics, LLC |
Robert A. Philibert, M.D., Ph.D. |
Methylation and GxMethylation Effects in Predicting Cardiovascular Disease |
|
Cardio Diagnostics, LLC |
Robert A. Philibert, M.D., Ph.D. |
Methylation and GxMethylation Effects in Predicting Stroke, Congestive Heart Failure and Diabetes |
|
CartilaGen, Inc. |
Marc Brouillette, Ph.D. |
A Novel Preventive Therapy for Post-Traumatic Osteoarthritis Focused on Acute Inhibition of Mitochondrial Electron Transport |
|
CartilaGen, Inc. |
Mitchell Coleman, Ph.D. |
A Novel Preventive Therapy for Post-Traumatic Osteoarthritis Focused on Acute Inhibition of Mitochondrial Electron Transport |
|
CartilaGen, Inc. |
Tae-Hong Lim, Ph.D. |
A Novel Preventive Therapy for Post-Traumatic Osteoarthritis Focused on Acute Inhibition of Mitochondrial Electron Transport |
|
CartilaGen, Inc. |
James A. Martin, Ph.D. |
A Novel Preventive Therapy for Post-Traumatic Osteoarthritis Focused on Acute Inhibition of Mitochondrial Electron Transport |
|
ChromaDex, Inc. |
Charles Michael Brenner, Ph.D. |
Nicotinoyl Ribosides and Derivatives for the Improvement of Maternal and Neonatal Health |
|
ChromaDex, Inc. |
Ankita Chadda |
Nicotinoyl Ribosides and Derivatives for the Improvement of Maternal and Neonatal Health |
|
ChromaDex, Inc. |
Po Hien Ear, Ph.D. |
Nicotinoyl Ribosides and Derivatives for the Improvement of Maternal and Neonatal Health |
|
Cura Medical Technologies, LLC |
Alan denBleyker, Ph.D. |
System and Method of Rule-Based Automatic Electronic Chart Checking System in Radiation Therapy |
|
Cura Medical Technologies, LLC |
Junyi Xia, Ph.D. |
System and Method of Rule-Based Automatic Electronic Chart Checking System in Radiation Therapy |
|
DASH Analytics LLC |
John W. Cromwell, M.D. |
Software for Predicting Surgical Site Infection in Surgical Patients |
|
DASH Analytics LLC |
Nick Street, Ph.D. |
Software for Predicting Surgical Site Infection in Surgical Patients |
|
Environmental and Cultural Research Logic, LLC |
Mary De La Garza |
Mobile App for Field Sciences |
|
Environmental and Cultural Research Logic, LLC |
John F. Doershuk, Ph.D. |
Mobile App for Field Sciences |
|
Esco Ventures (Carmentix Private Limited) |
Justin L. Grobe, Ph.D. |
Prediction and Treatment of Preeclampsia: Arginine Vasopressin Gene Products |
|
Esco Ventures (Carmentix Private Limited) |
Justin L. Grobe, Ph.D. |
Prediction of Preeclampsia |
|
Esco Ventures (Carmentix Private Limited) |
Justin L. Grobe, Ph.D. |
Apelin in the Prediction of Preeclampsia |
|
Esco Ventures (Carmentix Private Limited) |
Donna A. Santillan, Ph.D. |
Prediction and Treatment of Preeclampsia: Arginine Vasopressin Gene Products |
|
Esco Ventures (Carmentix Private Limited) |
Donna A. Santillan, Ph.D. |
Prediction of Preeclampsia |
|
Esco Ventures (Carmentix Private Limited) |
Mark K. Santillan, M.D. |
Prediction and Treatment of Preeclampsia: Arginine Vasopressin Gene Products |
|
Esco Ventures (Carmentix Private Limited) |
Mark K. Santillan, M.D. |
Prediction of Preeclampsia |
|
Esco Ventures (Carmentix Private Limited) |
Mark K. Santillan, M.D. |
Apelin in the Prediction of Preeclampsia |
|
Esco Ventures (Carmentix Private Limited) |
Curt D. Sigmund, Ph.D. |
Prediction and Treatment of Preeclampsia: Arginine Vasopressin Gene Products |
|
Esco Ventures (Carmentix Private Limited) |
Curt D. Sigmund, Ph.D. |
Prediction of Preeclampsia |
|
HyperSolar |
Wei Cheng, Ph.D. |
An Integrated Membrane-Solar Fuel Production Assembly for Reducing Ohmic Losses and Product Separation |
|
HyperSolar |
Syed Mubeen Jawahar Hussaini, Ph.D. |
An Integrated Membrane-Solar Fuel Production Assembly for Reducing Ohmic Losses and Product Separation |
|
IDx, LLC |
Michael D. Abramoff, M.D., Ph.D. |
Automated Prediction of Glaucoma Loss from Optical Coherence Tomography |
|
IDx, LLC |
Michael D. Abramoff, M.D., Ph.D. |
Deep Learning Based n-Dimensional Segmentation |
|
IDx, LLC |
Milan Sonka, Ph.D. |
Automated Prediction of Glaucoma Loss from Optical Coherence Tomography |
|
IDx, LLC |
Xiaodong Wu, Ph.D. |
Deep Learning Based n-Dimensional Segmentation |
|
Immortagen, LLC |
Donghai Dai, M.D., Ph.D. |
Method to Identify the Driver Mutations in a Patient Tumor |
|
InnoBiopharma, LLC |
Zhendong Jin, Ph.D. |
Design and Synthesis of a Potent Anticancer Agent ZJ101 |
|
InnoBiopharma, LLC |
Zhendong Jin, Ph.D. |
Synthesis of Designed Analogs of the Potent Anticancer Agent OSW-1 |
|
Innovative NeuroTechnologies, Inc. |
Gloria Lee, Ph.D. |
Monoclonal Antibody Recognizing Tau Phosphorylated at Tyrosine 18 |
|
Innovus Pharmaceuticals, Inc. |
Denice Marie Hodgson-Zingman, M.D. |
Musclin for Increased Muscle Growth and Performance and Resistance to Injury and Atrophy |
|
Innovus Pharmaceuticals, Inc. |
Rajan Sah, M.D., Ph.D. |
Use of Thymol and Carvacrol (monoterpene phenols) for Induction of Increased Skeletal Muscle Endurance, Lean Muscle Mass and Reduced Adiposity |
|
Innovus Pharmaceuticals, Inc. |
Leonid V. Zingman, M.D. |
Musclin for Increased Muscle Growth and Performance and Resistance to Injury and Atrophy |
|
Jounce Therapeutics, Inc. |
Gail A. Bishop, Ph.D. |
Immune Banking: Exploiting Pre-Existing Humoral Responses to Enhance Efficacy of New Vaccines |
|
Jounce Therapeutics, Inc. |
Gail A. Bishop, Ph.D. |
Human Recognized Epitope from Polio Virus Protection VP1 |
|
Jounce Therapeutics, Inc. |
Gail A. Bishop, Ph.D. |
Immune Banking Oncology Vaccine |
|
KLS-Martin LP |
Kingsley Otsioren Abode-Iyamah, M.D. |
Iowa Cranioplasty Plate (ICP) |
|
KLS-Martin LP |
Oliver Elias Flouty, M.D. |
Iowa Cranioplasty Plate (ICP) |
|
KLS-Martin LP |
Brian James Green |
Iowa Cranioplasty Plate (ICP) |
|
KLS-Martin LP |
Nicole M. Grosland, Ph.D. |
Iowa Cranioplasty Plate (ICP) |
|
KLS-Martin LP |
C. Allan Guymon, Ph.D. |
Iowa Cranioplasty Plate (ICP) |
|
KLS-Martin LP |
Matthew A. Howard, III, M.D. |
Iowa Cranioplasty Plate (ICP) |
|
KLS-Martin LP |
Matthew A. Howard, III, M.D. |
Iowa Cranial Plate (ICP) Rapid Skull Surface Template Matching and Implant Selection Concept |
|
KLS-Martin LP |
Matthew A. Howard, III, M.D. |
All-Metal Iowa Cranial Plate (AM-ICP) |
|
KLS-Martin LP |
Kirsten E. Stoner |
Iowa Cranioplasty Plate (ICP) |
|
NaturemiRI, LLC |
Brad A. Amendt, Ph.D. |
A Plasmid-Based microRNA Inhibitor System |
|
NaturemiRI, LLC |
Brad A. Amendt, Ph.D. |
miRNA-200c-based Approaches to Treat Inflammation-Induced Bone and Cartilage Loss and Degeneration |
|
NaturemiRI, LLC |
Brad A. Amendt, Ph.D. |
MicroRNA-200a Based Approaches for Modulating Bone Formation Inhibition and Bone Regeneration |
|
NaturemiRI, LLC |
Gustavo Avila Ortiz, D.D.S., Ph.D. |
miRNA-200c-based Approaches to Treat Inflammation-Induced Bone and Cartilage Loss and Degeneration |
|
NaturemiRI, LLC |
Christopher A. Barwacz, D.D.S., M.S. |
miRNA-200c-based Approaches to Treat Inflammation-Induced Bone and Cartilage Loss and Degeneration |
|
NaturemiRI, LLC |
Kim A. Brogden, Ph.D. |
miRNA-200c-based Approaches to Treat Inflammation-Induced Bone and Cartilage Loss and Degeneration |
|
NaturemiRI, LLC |
Satheesh Elangovan, D.D.S., Ph.D. |
miRNA-200c-based Approaches to Treat Inflammation-Induced Bone and Cartilage Loss and Degeneration |
|
NaturemiRI, LLC |
Liu Hong, M.D., M.S., Ph.D. |
miRNA-200c-based Approaches to Treat Inflammation-Induced Bone and Cartilage Loss and Degeneration |
|
NaturemiRI, LLC |
Liu Hong, M.D., M.S., Ph.D. |
MicroRNA-200a Based Approaches for Modulating Bone Formation Inhibition and Bone Regeneration |
|
NaturemiRI, LLC |
Aliasger K. Salem, Ph.D. |
miRNA-200c-based Approaches to Treat Inflammation-Induced Bone and Cartilage Loss and Degeneration |
|
NaturemiRI, LLC |
Aliasger K. Salem, Ph.D. |
MicroRNA-200a Based Approaches for Modulating Bone Formation Inhibition and Bone Regeneration |
|
Nuclease Probe Technologies, Inc. |
Elliot L. Burghardt |
Rapid and Sensitive Detection of Coliform Escherichia coli |
|
Nuclease Probe Technologies, Inc. |
Karen C. Clark |
Oligonucleotide-Based Probes for Detection of Bacterial Nucleases |
|
Nuclease Probe Technologies, Inc. |
Karen C. Clark |
Rapid and Sensitive Detection of Coliform Escherichia coli |
|
Nuclease Probe Technologies, Inc. |
James O. McNamara, Ph.D. |
Oligonucleotide-Based Probes for Detection of Bacterial Nucleases |
|
Nuclease Probe Technologies, Inc. |
James O. McNamara, Ph.D. |
Rapid and Sensitive Detection of Coliform Escherichia coli |
|
Nuclease Probe Technologies, Inc. |
James O. McNamara, Ph.D. |
Digital Nuclease Detection |
|
QED Bioscience |
Michael A. Apicella, M.D. |
Monoclonal Antibody Protein with Activity Against Streptococcal Pneumoniae Type 5 Polysacchride |
|
QuantCAD, LLC |
Michael E. Flatte, Ph.D. |
Superlattice Optoelectronic Property Code |
|
QuantCAD, LLC |
Michael E. Flatte, Ph.D. |
LCAO Code for Local Impurity Properties |
|
QuantCAD, LLC |
Jonathon T. Olesberg, Ph.D. |
Superlattice Optoelectronic Property Code |
|
QuantCAD, LLC |
Jonathon T. Olesberg, Ph.D. |
AugerRate |
|
Rodeo Therapeutics Corporation |
Andrew A. Pieper, M.D., Ph.D. |
Benefits of 15-PDGH Inhibitor Compounds on Central Nervous System Function and Recovery from Injury |
|
Rutgers, The State University of New Jersey |
Jim Jung-Ching Lin, Ph.D. |
A Human Tropomyosin Isoform TC22 is a Useful Biomarker for Cancer Surveillance |
|
Shinva Medical Instruments (Shandong Xinhua Medical Instrument Co., Ltd.) |
Ge Wang, Ph.D |
Energy-Sensitive Reconstruction Methods for Computed Tomography Based on a Single Scan with an Energy-Integrating Detector |
|
Shinva Medical Instruments (Shandong Xinhua Medical Instrument Co., Ltd.) |
Yangbo Ye, Ph.D |
Energy-Sensitive Reconstruction Methods for Computed Tomography Based on a Single Scan with an Energy-Integrating Detector |
|
University of Texas Southwestern Medical Center |
Matthew M. Harper, Ph.D. |
Restoration of Vision after Corneal Injury with Two Novel Small Molecule Compounds |
|
University of Texas Southwestern Medical Center |
Andrew A. Pieper, M.D., Ph.D. |
Discovery of (+)-P7C3-S243, a Neuroprotective Aminopropyl Carbazole with Improved Drug-Like Properties |
|
University of Texas Southwestern Medical Center |
Andrew A. Pieper, M.D., Ph.D. |
Restoration of Vision after Corneal Injury with Two Novel Small Molecule Compounds |
|
ViewPoint Molecular Targeting, LLC |
Frances Johnson, M.D. |
Antioxidant-Loaded Nanozymes to Protect the Renal System and Block Renal Uptake of Drugs for Therapy and Diagnosis and Monitoring of Disease |
|
ViewPoint Molecular Targeting, LLC |
Mengshi Li |
Antioxidant-Loaded Nanozymes to Protect the Renal System and Block Renal Uptake of Drugs for Therapy and Diagnosis and Monitoring of Disease |
|
ViewPoint Molecular Targeting, LLC |
Michael K. Schultz, Ph.D. |
Antioxidant-Loaded Nanozymes to Protect the Renal System and Block Renal Uptake of Drugs for Therapy and Diagnosis and Monitoring of Disease |
|
Voyant Biotherapeutics, LLC |
Robert F. Mullins, Ph.D. |
Modulation of Macrophages and/or Dendritic Cells as a Means of Preventing, Halting, or Delaying Drusen Formation and Age-Related Macular Degeneration |
|
Voyant Biotherapeutics, LLC |
Richard J.H. Smith, M.D. |
Assessment of Factor H Gene Variations in Age-related Macular Degeneration |
|
Ximbio (Cancer Research Technology Limited) |
Michael A. Apicella, M.D. |
Haemophilus Influenzae Type b Strain A2 (Clone 7F3) |
|
Ximbio (Cancer Research Technology Limited) |
Michael A. Apicella, M.D. |
Haemophilus Influenzae Type b Strain A2 (Clone 6 E4) |
|
Ximbio (Cancer Research Technology Limited) |
Michael A. Apicella, M.D. |
ASGP-R (Asialo-Glycoprotein Receptor) on Host (Male) Epithelial Cells - Mouse IgM (Clone 6C2) |
|
Ximbio (Cancer Research Technology Limited) |
Michael A. Apicella, M.D. |
GlcNAcβ1-3Galβ1-4Glc1-4Hep LOS on Neisseria Species (Clone 4C8) |
|
Ximbio (Cancer Research Technology Limited) |
Michael A. Apicella, M.D. |
H. Influenzae Mouse IgG 2b/k (Clone 4G10) |
|
Ximbio (Cancer Research Technology Limited) |
Michael A. Apicella, M.D. |
F. Tularensis Capsule Mouse IgM (Clone 10 E8) |
|
Ximbio (Cancer Research Technology Limited) |
Michael A. Apicella, M.D. |
Neisseria Gonorrhoeae Strain 1291 (Clone 6B4) |
|
Ximbio (Cancer Research Technology Limited) |
Michael A. Apicella, M.D. |
Neisseria Gonorrhoeae Strain 1291 (Clone 3F11) |
|
Ximbio (Cancer Research Technology Limited) |
Michael A. Apicella, M.D. |
Neisseria Gonorrhoeae Strain 1291 (Clone 4C4) |
|
Ximbio (Cancer Research Technology Limited) |
Kevin P. Campbell, Ph.D. |
Monoclonal Antibodies to the 1.4 Dihydropyridine Receptor of Ca21 Channel |
|
Ximbio (Cancer Research Technology Limited) |
Kevin P. Campbell, Ph.D. |
Identification and Characterization of the Protein Components of the Dystrophin Complex: 1)Identification of the Sarcolemma Glycoprotein(s) linked to Dystrophin. 2)Monoclonal Antibodies to the Dystrophin-Linked Glycoproteins |
|
Ximbio (Cancer Research Technology Limited) |
Kevin P. Campbell, Ph.D. |
Multiple Antibodies Under License to Affinity BioReagents |
|
Ximbio (Cancer Research Technology Limited) |
Kevin P. Campbell, Ph.D. |
Sodium-Potassium ATPase/HHMI |
|
Ximbio (Cancer Research Technology Limited) |
Kevin P. Campbell, Ph.D. |
(a)Ad1/20A6 (Licensed to Novocastra)(b)Monoclonal Antibody 35DAG/21B5 (licensed to Novocastra) |
|
Ximbio (Cancer Research Technology Limited) |
Amy Lee, Ph.D. |
Anti-Peptide Cav1.3 Antibodies |
|
Ximbio (Cancer Research Technology Limited) |
Amy Lee, Ph.D. |
Rabbit Polyclonal Cav 1.4 Antibodies |
The Office of the Vice President for Research and Economic Development provides resources and support to researchers and scholars at the University of Iowa and to businesses across Iowa with the goal of forging new frontiers of discovery and innovation and promoting a culture of creativity that benefits the campus, the state, and the world. More at http://research.uiowa.edu, and on Twitter: @DaretoDiscover.